Trazalon 25 Tablet
Trazodone
25mg
Sun Pharmaceutical Industries Ltd.
| Pack size | 1 |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 4.35 NPR |
Available as:
Indications
Trazalon 25 Tablet is used for:
Depression, Anxiety, Insomnia, Prevention of Migraine
Adult Dose
Oral
Depression
Adult: Initially, 150 mg daily increased by 50-mg increments every 3-4 days up to 300-400 mg daily if necessary. Daily dosage may be given in divided doses or as a single dose at night. Max: 600 mg daily in divided doses in severely depressed patients.
Elderly: Initially, 100 mg daily up to 300 mg daily. Daily dosage may be given in divided doses or as a single dose at night.
Anxiety
Adult: Initially, 75 mg daily increased to 300 mg daily if necessary. Daily dosage may be given in divided doses or as a single dose at night.
Hepatic impairment: Severe: use with caution.
Child Dose
Renal Dose
Renal impairment: Severe: use with caution.
Administration
Should be taken with food. Take shortly after a meal or a light snack.
Contra Indications
Immediate recovery phase post MI, porphyria. Pregnancy.
Precautions
Cardiovascular disorders, epilepsy, severe hepatic or renal insufficiency. Lactation. Monitor closely during initial therapy for signs of suicide. Discontinue if signs of hepatic dysfunction, blood dyscrasias or prolonged erection. Withdraw gradually. May impair ability to drive or operate machinery.
Pregnancy-Lactation
Interactions
May diminish action of some antihypertensives (e.g. clonidine). Increased trazodone concentrations with potent CYP3A4 inhibitors such as azole antifungals, HIV-protease inhibitors and macrolides. Reduced trazodone concentrations with CYP3A4 inducers such as carbamazepine. Increased risk of excessive hypotension and hepatotoxicity with phenothiazines. Decreased anticoagulant effect of warfarin. Increased digoxin or phenytoin levels with trazodone. Increased risk of neurotoxicity, serotonin syndrome with lithium. Sedative effect enhanced by alcohol and other CNS depressants (sedatives, hypnotics, antihistamines, opioid analgesics).
Potentially Fatal: Dangerous combination with MAOIs. Trazodone should not be given within 2 wk of discontinuing MAOIs and MAOIs should not be started within 1 wk of discontinuing trazodone.
Adverse Effects
Side effects of Trazodone :
Drowsiness, dizziness, restlessness, confusional state, headache, nausea, vomiting, weakness, weight loss, dry mouth, constipation, diarrhoea, tremor, bradycardia or tachycardia, orthostatic hypotension, oedema, blurred vision, priapism, skin rash, syndrome of inappropriate secretion of antidiuretic hormone.
Potentially Fatal: Blood dyscrasias, hepatocellular damage, neuroleptic maglignant syndrome.
Mechanism of Action
Trazodone is a triazolopyridine antidepressant which selectively inhibits serotonin re-uptake at presynaptic neurons. Unlike TCAs, peripheral re-uptake of noradrenaline is not affected. It does not have very significant antimuscarinic properties but has a marked sedative action.
Note
Trazalon 25 25mg Tablet manufactured by Sun Pharmaceutical Industries Ltd.. Its generic name is Trazodone. Trazalon 25 is availble in Nepal.
Farmaco Nepal drug index information on Trazalon 25 Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.